France
Sabouret P et al. REACH: international prospective observational registry in patients at risk of atherothrombotic events. Results for the French arm at baseline and one year. Arch Cardiovasc Dis. 2008;101(2):81-88.
PubMed Abstract
Germany
Parhofer KG et al. In Germany Diabetic Patients with Coronary Artery Disease are Treated More Intensively than Diabetic Patients with Other Manifestations of Atherothrombosis – Results from the REACH Registry. Exp Clin Endocrinol Diabetes 2009. DOI 10.1055/s-0029-1225648.
PubMed Abstract
Zeymer U et al. Risk factor profile, management and prognosis of patients with peripheral arterial disease with or without coronary artery disease: results of the prospective German REACH registry cohort.
Published online at Clin Res Cardiol.
PubMed Abstract
Singapore
Yeo TC, Chan YH, Low LP et al. Risk Factor Profile and Treatment Patterns of Patients with Atherothrombosis in Singapore: Insight from the REACH Registry. Ann Acad Med Singapore. 2008; 37(5): 365�367
PubMed Abstract
Australia
Ademi Z et al. Economic implications of obesity among people with atherothrombotic disease. Int J Obes (Lond). 2010 Mar 2. [Epub ahead of print]
PubMed abstract
Ademi Z et al. The economic implications of treating atherothrombotic disease in Australia, from the government perspective. Clin Ther. 2010; 32:119-132.
PubMed abstract
Ademi Z et al. Drug treatment and cost of cardiovascular disease in Australia. Cardiovasc Ther. 2009;27:164-72.
PubMed abstract
Reid C et al. Australians at risk: management of cardiovascular risk factors in the REACH Registry. Heart Lung Circ. 2008;17(2):114-118.
PubMed abstract
Israel
Barski L et al. Prevalence, recognition and treatment of cardiovascular risk factors in outpatients with atherothrombosis in Israel. Isr Med Assoc J. 2007;9(5):376-379.
PubMed abstract
Japan
Uchiyama S et al. Cardiovascular event rates in patients with cerebrovascular disease and atherothrombosis at other vascular locations: Results from 1-year outcomes in the Japanese REACH Registry.. J Neurol Sci. 2009 Oct 6. [Epub ahead of print].
PubMed abstract
Yamazaki T et al. Prevalence, awareness and treatment of cardiovascular risk factors in patients at high risk of atherothrombosis in Japan: Results from domestic baseline data of the Reduction of Atherothrombosis for Continued Health (REACH) Registry. Circ J 2007; 71(7):995�1003.
PubMed abstract
Spain
REACH Registry supplement in Med Clin (Barc):
Steg G. [Optimizing overall risk reduction: implications of the REACH registry. Introduction]. Med Clin (Barc). 2009;132 Suppl 2:1. [article in Spanish].
Castillo J et al. [Atherothrombosis: an excessively globalizing concept?]. Med Clin (Barc). 2009;132 Suppl 2:2-4. [article in Spanish].
PubMed abstract
Esmatjes E et al. [The REACH registry: baseline and 1-year results]. Med Clin (Barc). 2009;132 Suppl 2:5-9. [article in Spanish].
PubMed abstract
Suárez C et al. [One-year data from the REACH registry in Spain]. Med Clin (Barc). 2009;132 Suppl 2:10-4. [article in Spanish].
PubMed abstract
de la Villa Redondo BG. [Implications of the REACH registry for cardiologists]. Med Clin (Barc). 2009;132 Suppl2:15-20. [article in Spanish].
PubMed abstract
Alonso G. [Implications of the REACH registry for endocrinologists]. Med Clin (Barc). 2009;132 Suppl 2:21-4. [article in Spanish].
PubMed abstract
Alvarez-Fernández LJ et al. [Implications of the REACH registry for vascular surgery]. Med Clin (Barc). 2009;132 Suppl 2:25-9. [article in Spanish].
PubMed abstract
Roquer J. [Implications of the REACH registry for neurologists]. Med Clin (Barc). 2009;132 Suppl 2:30-3. [article in Spanish].
PubMed abstract
Ramos Salado JL. [Implications of the REACH registry for internal medicine]. Med Clin (Barc). 2009;132 Suppl 2:34-7. [article in Spanish].
PubMed abstract
Suárez C et al. [Pharmacoeconomic analysis: results of the REACH registry]. Med Clin (Barc). 2009;132 Suppl 2:41-3. [article in Spanish].
PubMed abstract
Gómez Cerezo JF. [Use of drugs in the REACH registry: from guidelines to clinical practice]. Med Clin (Barc). 2009;132 Suppl 2:44-6. [article in Spanish].
PubMed abstract
Suárez C. Baseline characteristics of patients with cerebrovascular disease in the REACH registry: the Spanish contribution.Cerebrovasc Dis 2007; 24(Suppl1): 89-95.
PubMed abstract
Suárez et al. Controle de factoresde riesgo y tratamiento de la aterotrombosis. Registro REACH Esp-na [Risk factor control and treatment of atherothrombosis. REACH Registry Spain]. Med Clin (Barc) 2007; 129(14):534-41 [Article in Spanish]
No abstract available
Taiwan
Cheng TJ et al. Underrecognition and undertreatment of atherothrombotic diseases: REACH Registry Taiwan baseline data. J Formos Med Assoc. 2007;106(7):548-557.
PubMed abstract
United Kingdom
Morrell J et al. Baseline data from the UK arm of the REACH Registry. Br J Cardiol 2007; 14:153�159.
PDF available on journal website
Bhatt DL and Steg PG. REACHing for new heights in disease management (editorial). Br J Cardiol� 2007; 14:90.
PDF available on journal website
Morrell J et al. One-year data from the UK arm of the REACH Registry. Br J Cardiol 2007; 14:215�218+G36.
PDF available on journal website
Morrell J et al. Optimising global risk reduction: Insights from the REACH Registry. Br J Cardiol 2007; 14: Suppl 3
PDF available on journal website
Publication guidelines:
Do you want to submit a proposal for publication?
Refer to the Publication guidelines section for details.
